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Unsymmetric vesicles with a different design on
each side for near-infrared fluorescence imaging of
tumor tissues†
Akihiro Uesaka,a Isao Hara,b Tomoya Imai,c Junji Sugiyamac and Shunsaku Kimura*a
Spherical vesicular assemblies with unsymmetric membranes are prepared from A3B-type and AB0-type
peptides with different helix senses in the hydrophobic B and B0 blocks under the control of three
associated factors: stereo-complex formation, dipole–dipole interactions, and steric effects. [(Sar)26]3-b-
(L-Leu-Aib)6 (A3BL), (Sar)27-b-(L-Leu-Aib)6 (ABL), (Sar)28-b-(D-Leu-Aib)6 (ABD), lipoic-acid terminated ABL
(lipoABL), and lipoic-acid terminated ABD (lipoABD) are mixed while keeping equimolar ratios of the total
amounts of the right- and the left-handed helices. When A3BL exceeds more than 60% of all the right-
handed helices of the mixture, the unsymmetric vesicles are formed, as indicated by the selective
adsorption of gold nanoparticles on the vesicle surface observed by TEM. The unsymmetric vesicles are
also prepared using ICGABL and ICGABD with a near-infrared fluorophore, indocyanine green (ICG), at
the terminals of ABL and ABD. The unsymmetric vesicle formation is verified by fluorescence quenching
with the addition of In ions to the solution. When these vesicles are injected into tumor-bearing mice,
the vesicles are effectively accumulated into tumor tissues via the EPR effect. The unsymmetric vesicle
containing ICG at the inward surface induces less IgM production than that with ICG at the outward
surface. More stealth vesicles in the blood stream are therefore obtainable by concealing the imaging
fluorophores in the vesicle.
1. Introduction
Amphiphilic molecules self-assemble into molecular assem-
blies in water via various intermolecular interactions such as
hydrophobic and electrostatic interactions.1–5 Their morphol-
ogies depend heavily on the chemical structure of the compo-
nents, and suitable molecular designs have been proposed to
generate molecular assemblies with various morphologies and
sizes.6–8 In addition, molecular assemblies have been applied
for broad elds ranging from nanodevices to biomaterials.9–14
Among them, vesicles are one of the most frequently
appearing nanocarriers for tumor-targeted drug delivery and
molecular imaging.15–20 In tumor tissues, the vascular walls have
submicron holes because of rapid angiogenesis; therefore,
nanocarriers can permeate into tumors through the vascular
wall. Furthermore, the lymph system around tumors grows so
slowly that nanocarriers are usually retained in the tumor. This
effect is called the enhanced permeability and retention (EPR)
effect.21 In this regard, the control of the nanocarrier size is
essential to allow them to be passively accumulated into tumor
tissues.18,22,23 Various vesicles of liposomes, polymersomes, and
peptosomes, which are prepared from lipids,24,25 polymers,26,27
and peptides,18,28 respectively, have been studied. One challenge
of vesicular molecular assemblies is to prepare unsymmetric
vesicles with different components between the outer and the
inner surfaces that mimic cell membranes. For example,
Fuhrhop reported that unsymmetric bolaamphiphiles with
small and large head groups self-assemble into unsymmetric
monolayer vesicles via steric effects.29,30 Furthermore, Xiao and
Pautot reported that reverse micelles were transformed into
lipid monolayers at the oil/water interface to form unsymmetric
vesicles.31,32 However, it is not so easy to prepare unsymmetric
membranes under precise control of the distribution of the
components. In addition, these methods do not seem to be
applicable to the unsymmetric self-assembly of amphiphilic
polymers due to the disordered packing and/or molecular
entanglement of the hydrophobic blocks.
We previously reported that le-handed helical peptides
with one hydrophilic chain (AB-type) and right-handed helical
peptides with three hydrophilic chains (A3B0-type) co-assemble
into unsymmetric peptosomes via stereo-complex formation,
dipole–dipole interactions, and steric effects.33 Stereo-complex
formation and dipole–dipole interactions can result in
aDepartment of Material Chemistry, Graduate School of Engineering, Kyoto University,
Kyoto-Daigaku-Katsura, Nishikyo-ku, Kyoto, 615-8510, Japan. E-mail: shun@scl.
kyoto-u.ac.jp; Fax: +81-75-383-2401; Tel: +81-75-383-2400
bTechnology Research Laboratory, Shimadzu Corporation, 3-9-4 Hikari-dai, Seika-cho,
Soraku-gun, Kyoto 619-0237, Japan
cResearch Institute for Sustainable Humanosphere (RISH), Kyoto University, Gokasho,
Uji, Kyoto 611-0011, Japan
† Electronic supplementary information (ESI) available. See DOI:
10.1039/c4ra15635h
Cite this: RSC Adv., 2015, 5, 14697
Received 2nd December 2014
Accepted 16th January 2015
DOI: 10.1039/c4ra15635h
www.rsc.org/advances























































































View Journal  | View Issue
regularly interdigitated helix packing to generate unsymmetric
planar sheets. The planar sheets grew into unsymmetric vesicles
due to the steric effect of the bulky hydrophilic A3 moieties of
the A3B-type peptides extruding to the outer surface. Further-
more, the selective surface modication at the outer or inner
surface can be easily performed by choosing the right-handed or
le-handed helix of the functionalised helical peptides.
In this paper, we study a necessary proportion of the A3B-
type helix, [(Sar)26]3-b-(L-Leu-Aib)6 (A3BL), for the generation
of unsymmetric vesicles in mixtures of the A3B-type right-
handed helical peptide (A3BL), AB-type right-handed helical
peptide, (Sar)27-b-(L-Leu-Aib)6 (ABL), AB-type le-handed
helical peptide, (Sar)28-b-(D-Leu-Aib)6 (ABD), and two AB-type
helical peptides with lipoic acid at the termini of the hydro-
philic chains, lipoABL and lipoABD (Fig. 1). Lipoic acid at the
terminal of the poly(sarcosine) chain has been shown to behave
as a hydrophilic group in these molecular assemblies.33,34
Unsymmetric vesicles about the location of near-infrared
uorescent (NIRF) probe are also prepared here using the
novel functional AB-type helical peptides modied with
indocyanine green (ICG), ICGABL and ICGABD (Fig. 1). Using
these two types of unsymmetric vesicles, one with ICG groups
on the outer surface and the other with ICG groups on the inner
surface, we examine the in vivo distributions of these vesicles
and the IgM productions in tumor-bearing mice to obtain
information of the effect of surface modication on the phar-
macokinetics of the vesicles.
2. Experimental section
2.1 Materials
The amphiphilic peptides A3BL, ABL, ABD, lipoABL and lip-
oABD were obtained as reported previously.33,34 ICGABL and
ICGABD were synthesised according to Scheme S1 (ESI†). The
synthetic details are described in the ESI.† The near-infrared
uorescence compound, ICG-sulfo-OSu, was purchased from
Dojin Laboratory Ltd. Au nanoparticles (AuNPs) were purchased
from BB international (U.K.) with an average diameter of 10 nm.
All reagents were purchased commercially and used as received
unless otherwise noted.
2.2 Preparation of molecular assembly
A solution of polypeptides in ethanol (0.05 mg mL1, 5.0 mL) was
injected into milliQ water under stirring at 4 C. In the case of
A3BL, methanol was used instead of ethanol. Aer 30 min, the
dispersion was heated by an aluminium heat source if neces-
sary, followed by cooling at room temperature for
measurements.
2.3 Transmission Electron Microscopy (TEM)
TEM images were collected using a JEOL JEM-2000EXII at an
accelerating voltage of 100 kV. Peptide aqueous solutions were
applied on a carbon-coated Cu grid, and the samples were
negatively stained with 2% uranyl acetate followed by suction of
the excess uid with a lter paper.
2.4 Frozen-hydrated/cryogenic-TEM (Cryo-TEM)
The peptide dispersions were quickly frozen in liquid ethane,
which was cooled with liquid nitrogen. The samples were
examined at an accelerating voltage of 100 kV at the tempera-
ture of liquid nitrogen.
2.5 Dynamic Light Scattering (DLS)
The DLS measurements were taken using a DLS-8000KS (Photal
Otsuka Electronics) with a He–Ne laser at 25 C. Before the DLS
measurements, each prepared sample was ltered using a
0.20 mm PVDF (polyvinylidene uoride) syringe lter (GE
Healthcare UK limited).
2.6 The adhesion of AuNPs to vesicles
Preliminarily, peptides with lipoic acid were mixed with the
solution of amphiphilic peptides, and the molecular assemblies
were prepared from the solutions according to the previously
described procedure.33 The peptide aqueous solutions were
applied on a carbon-coated Cu grid, and AuNPs with diameters
of 10 nm were then added on the grid to reduce the non-specic
association of AuNPs with vesicles. The lipoic acids on the
molecular assemblies can easily react with AuNPs on the Cu
grid.33,34 Aer washing the excess AuNPs with dispersion media,
Fig. 1 Chemical structures of amphiphilic block polypeptides A3BL, ABL, ABD, lipoABL, lipoABD, ICGABL, and ICGABD.






















































































the samples were negatively stained with 2% uranyl acetate
followed by suction of the excess uid with a lter paper.
2.7 Fluorescent analysis
The uorescent spectra of the peptide dispersions were
obtained using a JASCO FP-6600 spectrouorometer at an
optional temperature with a transmission cell with an optical
path length of 1 cm. Before measurements, vesicle suspensions
were diluted to 0.05 mg mL1 (in a total volume of 2.0 mL). The
excitation wavelength of ICG is 755 nm.
2.8 In vivo NIRF-imaging of vesicles with ICG
SUIT2/pEF/LUC cells (5  105 cells) were dissolved in PBS
(20 mL) and subcutaneously inoculated into the right femoral
region of seven-week-old BALB/c nu/nu mice (n ¼ 3 per group).
Vesicles containing ICG were prepared in milliQ water,
and NaCl was added into the suspensions to adjust to physio-
logical conditions (0.9 wt% NaCl aq.). The vesicle suspensions
(5 mg kg1, 100 mL) were injected into the mice via the tail vein
one week aer the tumor transplantation. The amount of
injected ICG was 10 nmol kg1. NIRF images (Ex, 785 nm; Em,
845 nm) were taken at 15 min, 1 h, 3 h, 6 h, 9 h, and 24 h aer
the dose. During the imaging process, themice were held on the
imaging stage under anesthetised conditions with 2.5% of iso-
urane gas in air ow (1.5 L min1). The pseudo images were
constructed from the photon counts.
2.9 IgM assay
For ELISA, vesicles (5 mg kg1, 100 mL) were injected to the
BALB/c nu/nu mice, which were purchased from Japan SLC, Inc.
(Japan; n ¼ 3 per group). Mouse blood was collected in 1.5 mL
tubes from the inferior vena cava under anaesthesia conditions
at one week aer administration. The serum was kept overnight
at 4 C. The next day, the serum was obtained by centrifugation
(10 min, 3000 rpm) and saved at 40 C.
Lactosomes prepared from [poly(Sar)50]3-b-poly(L-lactic
acid)30 in 50 mL acetonitrile were added to 96-well plates (0.5 mg
per well) and air dried completely for one day. Then, 150 mL of
blocking buffer [2% BSA/phosphate-buffered saline (PBS)] was
added and incubated for 2 h. The wells were washed four times
with washing buffer (PBS-T: 0.05% tween 20 in PBS). The serially
diluted sera were added to the wells and incubated for 2 h. Aer
incubation, the wells were washed four times with PBS-T.
Peroxidase-conjugated goat-anti-mouse IgM in 0.1% BSA/PBS
(50 mL, Southern Biotech, USA) was added as the secondary
antibody. Aer the solution was incubated for 2 h, the wells
were again washed four times with PBS-T. o-Phenylenediamine
(0.5 mg mL1, Sigma, St Louis, MO) dissolved in 0.0003% H2O2-
0.1 M citrate phosphate buffer (pH 5.0) was added to the wells.
At 10 min aer the o-phenylenediamine addition, the OD was
determined at 490 nm with 620 nm as a reference.
2.10 Statistical analysis
All results are expressed as mean  SD. Differences between
groups in amount of AuNPs attached on vesicles, IgM
production and NIRF-imaging studies were assessed by the t-
test for independent samples. P-values <0.05 and <0.01 were
considered statistically signicant and designated by * and **,
respectively.
2.11 Ethics
All of our in vivo animal experiments were approved by the
animal research committee of Kyoto University. The animals
were treated humanely.
3. Results and discussions
3.1 Preparation of unsymmetric vesicles
A3BL and ABD were co-assembled into planar sheets with
lengths of ca. 150 nm in milliQ water (Fig. 2a), and these sheets
were transformed into vesicles with diameters of ca. 90 nm
upon heating at 90 C for 1 h (Fig. 2b). DLS measurements
showed that the vesicle diameter was 99.6 nmwith a narrow size
distribution (PDI¼ 0.052). These results suggest that the stereo-
complex formation contributes to the formation of the planar
sheet morphology, and the subsequent heat treatment triggers
vesicle formation so as to reduce the hydrophobic edges in
water, as reported previously.33–35
To study the unsymmetry of the vesicle, lipoABL and lip-
oABD, which can bind AuNPs, were incorporated into the vesi-
cles prepared from A3BL and ABD, respectively.33 In a previous
paper, we demonstrated that lipoic acid at the hydrophilic chain
terminal behaves as a hydrophilic moiety.33,34 If the lipoic acids
of amphiphilic peptides are oriented towards the inside of
vesicles, AuNPs should not adhere to the vesicles, which can be
visualised by TEM to provide information on the peptide
orientation in the membrane. AuNPs adhered clearly to the
vesicles prepared from A3BL + ABD + lipoABL (0.4/0.5/0.1, mol/
mol/mol; Fig. 3a and S2a of ESI†), whereas few AuNPs adhered
to the vesicles prepared from A3BL + ABD + lipoABD (0.5/0.4/0.1,
mol/mol/mol; Fig. 3b and S2b of ESI†). The TEM images show
the collapsed vesicles due to the vacuum condition of the TEM
observation, but the morphology was conrmed to be spherical
by cryo-TEM observation (Fig. 5). These results indicate that the
unsymmetric vesicles were formed from the ternary mixtures,
and the functionalised peptides with lipoic acid were integrated
into the membrane under control of the molecular orientation
according to the right- or le-handed helical sense of the
functionalised peptides.
Fig. 2 TEM images (negative stain with 2% uranyl acetate) of molec-
ular assemblies prepared from A3BL and ABD in milliQ water (a) before
and (b) after heat treatment at 90 C for 1 h. Scale bars are 200 nm.






















































































3.2 The effect of A3BL proportion on unsymmetric
membranes
To evaluate the proportion of A3BL in all the right-handed
helices necessary to achieve the unsymmetric vesicles by
steric effects, the compositions of ABL and A3BL were varied
(Fig. 4). As described above, several AuNPs adhered to the
vesicles of A3BL + ABD + lipoABL (0.4/0.5/0.1, mol/mol/mol),
but few AuNPs adhered to those of A3BL + ABD + lipoABD
(0.5/0.4/0.1, mol/mol/mol). The extent of the latter AuNP
adherence was similar to that to the vesicles without the lipoic
acid-modied peptides (Fig. S3e of ESI†), suggesting the
nonspecic adherence of AuNPs in these cases. The quaternary
mixture vesicle of A3BL, ABL, ABD, and lipoABL (0.30/0.10/0.50/
0.10, vesicle c in Fig. 4), which corresponds to a 60% propor-
tion of the A3B-type peptide in all the right-handed helices,
clearly attached to AuNPs (Fig. S3a of ESI†). On the other hand,
when lipoABL was replaced by lipoABD with the same 60%
proportion of the A3B-type peptide in all the right-handed
helices, the quaternary mixture vesicle of A3BL, ABL, ABD,
and lipoABD (0.30/0.20/0.40/0.10, vesicle d in Fig. 4) attached
to signicantly fewer AuNPs (Fig. S3b of ESI†). It is therefore
indicated that the orientation of the peptides should be
maintained in the unsymmetric way even in the vesicles con-
taining a 60% proportion of the A3B-type peptide. The numbers
of AuNPs adhered per unit surface area of the vesicles in the
TEM images were counted, and the data were analysed statis-
tically (Fig. 4). The selective adherence of AuNPs to vesicles a, b,
c, and d was conrmed statistically by a p-value of less than
0.01. It is therefore concluded that all the right-handed helices
in these vesicles should orient towards the outside of the
vesicle.
However, when the proportion of the A3B-type peptide
decreased to 50% in all the right-handed helices (vesicles e and f
in Fig. 4), the extent of AuNP adherence was similar between
these vesicles (Fig. S3c and d of ESI†). These results suggest that
the molecular direction of helices in the membrane cannot be
controlled when the vesicles contain less than 50% A3B-type
peptide in all the right-handed helices.
The DLS measurements revealed that the vesicle diameter
increased by increasing the proportion of ABL or, in other
words, by decreasing the proportion of A3BL (Fig. S4 of ESI†).
This result suggests that substituting AB-type peptides for bulky
A3B-type peptides decreases the curvature of the vesicles.
Furthermore, the diameter increases sharply when the propor-
tion of ABL in all the right-handed helices is more than 50%.
This increase also supports the interpretation that bulky A3B-
type peptides start to orient towards the inside of some vesi-
cles when the proportion of ABL is more than 50%. From these
results, it is concluded that unsymmetric vesicles can be
prepared in the presence of A3BL at a proportion of greater than
60% in all the right-handed helices, and the functionalised
unsymmetric vesicles are applicable for some applications that
require unsymmetric membranes.
3.3 The application of unsymmetrical vesicles to NIRF
imaging
The unsymmetric vesicles were examined as nanocarriers
for the NIRF imaging of solid tumor. The ternary mixtures of
A3BL + ABD + ICGABL (0.48/0.5/0.02, mol/mol/mol) and A3BL +
ABD + ICGABD (0.5/0.48/0.02, mol/mol/mol) were self-
assembled into homogeneous vesicles in milliQ water (Fig. 5
and S5 of ESI†); the corresponding vesicle diameters deter-
mined by DLS were 111.7 nm and 111.5 nm, respectively,
which are in agreement with the previously described unsym-
metric vesicles. The cryo-TEM images conrm the formation of
vesicles, even in the presence of ICG-peptides in these
compositions (Fig. 5).
To conrm that vesicles containing ICG also have unsym-
metric membranes, aqueous InCl3 was added to the vesicle
suspension as a quencher because the hydrophilic poly-
(sarcosine) chains of vesicles have been suggested to adsorb
In3+ ions to effectively quench ICG uorescence via the heavy-
atom effect. When 10 mM aqueous InCl3 was added to vesicles
containing ICG-peptides, In3+ ions more effectively quenched
the uorescence from the vesicle containing ICGABL than from
Fig. 3 TEM images (negative stain with 2% uranyl acetate) of vesicles
prepared from (a) A3BL + ABD+ lipoABL and (b) A3BL + ABD+ lipoABD
in milliQ water upon heat treatment at 90 C for 1 h. An aliquot of a
10 nm AuNP suspension was added to the vesicles on the TEM grid.
Scale bars are 200 nm.
Fig. 4 The number of AuNPs per unit area (100  100 nm2) of vesicle
surface. The p-value: **p < 0.01.






















































































those containing ICGABD according to the Stern–Volmer plots
(Fig. 6). The molecular orientation of ICGABL and ICGABD in
each vesicle is therefore controlled to locate at the outside and
inside of the vesicles, respectively. In these ternary mixtures, the
A3BL proportions in all the right-handed helix peptides exceed
96%, and the unsymmetric vesicle formation from these ternary
mixtures is consistent with our interpretation of the relation-
ship between unsymmetry and composition.
The in vivo dispositions of vesicles containing ICGABL and
ICGABD in tumor-bearing mice were analysed by NIRF
imaging (Fig. 7 and S6 of ESI†). These vesicles were prepared in
milliQ water, and the concentration of NaCl was adjusted to
the physiological condition (0.9 wt%) by the addition of NaCl.
The hydrodynamic diameters of both vesicles before and aer
the salt addition were 112.8 nm (PDI of 0.080) and 109.0 nm
(PDI of 0.083), respectively. The integrity of the vesicle with the
added NaCl was also conrmed by cryo-TEM of the unsym-
metric vesicle prepared from A3BL + ABD; the membrane
maintained its impermeable property against FITC-dextran
incorporated into the vesicle upon the change of ionic
strength.33
The accumulated amounts of the vesicles in tumor in the
right femoral region and in the healthy part of the le femoral
region were estimated from the uorescence intensities of the
images. Fig. 7 shows that the vesicle containing ICGABD was
accumulated more in the tumor than the vesicle containing
ICGABL. Furthermore, the NIRF images obtained at 5 min aer
injection show that the vesicle containing ICGABD spread over
the entire body to uoresce more intensely than the vesicle
containing ICGABL (Fig. 7b). The vesicle concentration in the
blood stream at 5 min aer injection should be therefore be
higher for the vesicle containing ICGABD than for that con-
taining ICGABL. At the moment, the clearance time of the
vesicle could not be obtained due to signicant capture by the
liver; however, these observations support that the vesicle con-
taining ICGABD should remain in the blood stream longer than
the vesicle containing ICGABL, which induced the greater
accumulation of the former vesicle in tumors compared to the
latter. In the case of the vesicle containing ICGABD, the uo-
rophores were concealed in the unsymmetric vesicle, which
should diminish capture by the liver, especially for the ICG
uorophore.
Some nanoparticles have been reported to trigger IgM
production when they are dosed to mice.36–38 For example,
polymeric micelles prepared from poly(Sar)64-b-poly(L-lactic
acid)30 induced the production of anti-poly(sarcosine) IgM
and IgG with a long memory. The amounts of anti-
poly(sarcosine) IgM produced by the current vesicles were
analysed by ELISA using Lactosome as the positive control
(Fig. 8). The vesicles containing ICG-peptides triggered the
production of IgM but in less amounts compared with Lac-
tosome. Ishida et al. pointed out that the surface density
inuences the amount of IgM production.38 On the other
hand, we have reported that the high surface density of the
poly(sarcosine) chains of nanoparticles suppresses IgM
production.39 In the present case, the A3B-type peptide
extruded the bulky A3 moieties outside, and the helical blocks
were tightly packed due to stereo-complex formation. The
surface density of poly(sarcosine) should therefore be higher
with the current vesicles compared to with Lactosome. This
higher surface density might explain the ability of the current
vesicles to suppress IgM production even though the vesicles
have larger diameters (about 100 nm) compared to Lactosome
(35 nm).
The vesicle containing ICGABL triggered IgM production
more than the vesicle containing ICGABL. Since the ICG
moieties of the vesicle containing ICGABL are exposed to the
outside of the vesicle, the surface may have more defects
than the vesicle containing ICGABD, making recognition by
B cells easier. It is considered that the unsymmetric vesicles
also have different stimulation properties to the immune
system.
Fig. 5 TEM images (negative stain with 2% uranyl acetate) of vesicles
prepared from (a) A3BL+ ABD+ ICGABL and (c) A3BL + ABD+ ICGABD
in milliQ water upon heat treatment at 90 C for 1 h. Cryo-TEM images
of vesicles prepared from (b) A3BL + ABD + ICGABL and (d) A3BL +
ABD + ICGABD. Scale bars are 200 nm.
Fig. 6 Stern–Volmer plots of the fluorescence quenching of vesicles
containing ICGABL (blue squares) and ICGABD (red circles) by In3+
ions.























































































Unsymmetric vesicles were prepared from mixtures of A3B-type
right-handed helices and AB-type le-handed helices in milliQ
water utilising stereo-complex formation, dipole–dipole inter-
actions and steric effects. More than 60% A3B-type peptides in
all the right-handed helices is necessary to obtain unsymmetric
vesicles as a result of steric effects. In other words, the vesicles
can possibly contain up to 40% functionalised AB-type right-
handed helix peptide in all the right-handed helices where all
the functional groups are exposed to the outside of the vesicle.
Furthermore, the functional groups can be concealed in the
inner surface of the vesicle by using a functionalised AB-type
le-handed helix peptide. As shown in the present paper, the
vesicles show different behaviours regarding in vivo disposition
and reaction with the immune system depending on the loca-
tions of the function groups on the vesicle. We are currently
trying to increase the vesicle accumulation amount in tumors
and develop a bimodal imaging vesicle with the unsymmetric
vesicle.
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